| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Harry S Chapman last filed a Form 4 in December 2022, as Director at USPH. Harry S Chapman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Harry S Chapman a middling insider score of 58/100, based on 13 past trades. Over a 12-month horizon, 61.5% of those trades were profitable, with an average 12-month return of +2.0%.
At the last filing, the largest reported position was 6,740 shares of USPH. The USPH filings lean toward selling, a net 38,790 shares.
Harry S Chapman has 23 Form 4 filings on record from May 2015 to December 2022, all as Director at U S Physical Therapy (USPH), 2015–2022.
The 40 reported transactions were 23 open-market sales, 9 open-market purchases and 8 stock awards.
Counted by filing, the open-market trades come to 6 purchases worth about $905K and 10 sales worth about $4.1M.
The largest open-market purchase was 2,400 shares of USPH at an average $117.00 on November 11, 2019, about $281K.
The largest open-market sale was 8,000 shares of USPH at an average $115.09 on March 25, 2021, about $921K. Twelve months later USPH was down 11%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 4,160 | $84.09 | $349,814.40 | -38.2% | +13.9% | +5.2% | |
| Dec 15, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 3,000 | $86.00 | $258,002.58 | -21.6% | +8.8% | +3.3% | |
| Dec 2, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 8,600 | $90.82 | $781,052.00 | -38.2% | +11.2% | -3.5% | |
| Sep 12, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 5,000 | $80.50 | $402,500.00 | -18.2% | +10.2% | +17.0% | |
| Sep 6, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 5,000 | $76.72 | $383,590.00 | -15.4% | +18.0% | +27.8% | |
| Mar 17, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 1,280 | $96.02 | $122,905.60 | -4.0% | +10.1% | -2.7% | |
| Mar 15, 2022 | USPH U S Physical Therapy Inc /nv | Director | Sell | 3,320 | $94.75 | $314,586.00 | -9.4% | +15.4% | -0.0% | |
| Aug 27, 2021 | USPH U S Physical Therapy Inc /nv | Director | Sell | 2,000 | $116.12 | $232,230.00 | -5.3% | -24.0% | -27.1% | |
| Aug 6, 2021 | USPH U S Physical Therapy Inc /nv | Director | Buy | 2,020 | $116.84 | $236,026.20 | +5.7% | -3.9% | -17.9% | |
| Mar 25, 2021 | USPH U S Physical Therapy Inc /nv | Director | Sell | 8,000 | $115.09 | $920,710.00 | -19.5% | +6.3% | -10.9% |